208 related articles for article (PubMed ID: 19733372)
1. Effect of participation on the cumulative risk of false-positive recall in a breast cancer screening programme.
Molins E; Comas M; Román R; Rodríguez-Blanco T; Sala M; Macià F; Murta-Nascimento C; Castells X
Public Health; 2009 Sep; 123(9):635-7. PubMed ID: 19733372
[No Abstract] [Full Text] [Related]
2. Predicting the risk of a false-positive test for women following a mammography screening programme.
Njor SH; Olsen AH; Schwartz W; Vejborg I; Lynge E
J Med Screen; 2007; 14(2):94-7. PubMed ID: 17626709
[TBL] [Abstract][Full Text] [Related]
3. Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme.
Castells X; Molins E; Macià F
J Epidemiol Community Health; 2006 Apr; 60(4):316-21. PubMed ID: 16537348
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer screening: one life saved at a cost of three overdiagnosis.
BMJ; 2012 Nov; 345():e7460. PubMed ID: 23129492
[No Abstract] [Full Text] [Related]
5. The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program.
Hofvind S; Thoresen S; Tretli S
Cancer; 2004 Oct; 101(7):1501-7. PubMed ID: 15378474
[TBL] [Abstract][Full Text] [Related]
6. Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer.
Wu GH; Chen LS; Chang KJ; Hou MF; Chen SC; Liu TJ; Huang CS; Hsu GC; Yu CC; Jeng LL; Chen ST; Chou YH; Wu CY; Shin-Lan K; Chen TH;
J Med Screen; 2006; 13 Suppl 1():S23-7. PubMed ID: 17227638
[TBL] [Abstract][Full Text] [Related]
7. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
8. Participation behaviour following a false positive test in the Copenhagen mammography screening programme.
Andersen SB; Vejborg I; von Euler-Chelpin M
Acta Oncol; 2008; 47(4):550-5. PubMed ID: 18465321
[TBL] [Abstract][Full Text] [Related]
9. The contribution of clinical breast examination to the accuracy of breast screening.
Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
[TBL] [Abstract][Full Text] [Related]
10. Mammography screening and breast cancer mortality in Australia: an aggregate cohort study.
Morrell S; Taylor R; Roder D; Dobson A
J Med Screen; 2012 Mar; 19(1):26-34. PubMed ID: 22345322
[TBL] [Abstract][Full Text] [Related]
11. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
[TBL] [Abstract][Full Text] [Related]
12. False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes.
Hofvind S; Ponti A; Patnick J; Ascunce N; Njor S; Broeders M; Giordano L; Frigerio A; Törnberg S; ; Van Hal G; Martens P; Májek O; Danes J; von Euler-Chelpin M; Aasmaa A; Anttila A; Becker N; Péntek Z; Budai A; Mádai S; Fitzpatrick P; Mooney T; Zappa M; Ventura L; Scharpantgen A; Hofvind S; Seroczynski P; Morais A; Rodrigues V; Bento MJ; Gomes de Carvalho J; Natal C; Prieto M; Sánchez-Contador Escudero C; Zubizarreta Alberti R; Fernández Llanes SB; Ascunce N; Ederra Sanza M; Sarriugarte Irigoien G; Salas Trejo D; Ibáñez Cabanell J; Wiege M; Ohlsson G; Törnberg S; Korzeniewska M; de Wolf C; Fracheboud J; Patnick J; Lancucki L; Ducarroz S; Suonio E
J Med Screen; 2012; 19 Suppl 1():57-66. PubMed ID: 22972811
[TBL] [Abstract][Full Text] [Related]
13. [Using medical imaging for a comprehensive breast cancer screening program].
Dilhuydy MH
Bull Cancer; 2009 Nov; 96(11):1071-86. PubMed ID: 19887333
[TBL] [Abstract][Full Text] [Related]
14. Population screening for breast cancer by mammography in The Netherlands. Expectations, early results, negative effects and conditions for large-scale screening.
Hendriks JH; Verbeek AL
Diagn Imaging Clin Med; 1985; 54(3-4):186-91. PubMed ID: 3896616
[TBL] [Abstract][Full Text] [Related]
15. Screening and prevention of breast cancer in primary care.
Tice JA; Kerlikowske K
Prim Care; 2009 Sep; 36(3):533-58. PubMed ID: 19616154
[TBL] [Abstract][Full Text] [Related]
16. Psychological distress associated with organized breast cancer screening.
Steggles S; Lightfoot N; Sellick SM
Cancer Prev Control; 1998 Oct; 2(5):213-20. PubMed ID: 10093635
[TBL] [Abstract][Full Text] [Related]
17. False-positive mammographic screening: factors influencing re-attendance over a decade of screening.
Fitzpatrick P; Fleming P; O'Neill S; Kiernan D; Mooney T
J Med Screen; 2011; 18(1):30-3. PubMed ID: 21536814
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer screening gets risk-specific.
Peres J
J Natl Cancer Inst; 2013 Jan; 105(1):1-2. PubMed ID: 23257155
[No Abstract] [Full Text] [Related]
19. Predictors of breast cancer-related distress following mammography screening in younger women on a family history breast screening programme.
Brain K; Henderson BJ; Tyndel S; Bankhead C; Watson E; Clements A; Austoker J;
Psychooncology; 2008 Dec; 17(12):1180-8. PubMed ID: 18506670
[TBL] [Abstract][Full Text] [Related]
20. The cumulative risk of false-positive results in the Norwegian Breast Cancer Screening Program: updated results.
Roman M; Hubbard RA; Sebuodegard S; Miglioretti DL; Castells X; Hofvind S
Cancer; 2013 Nov; 119(22):3952-8. PubMed ID: 23963877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
